Why ASX software company FINEOS Corporation (ASX:FCL) could light up the market in FY21

The FINEOS Corporation Holdings plc (ASX:FCL) share price is already up 90% so far this year. But the best might still be yet to come for this leading ASX insurance software developer.

| More on:
asx share price to shine in 2021 represented by the numbers 2021 lit up against night sky

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in insurance software developer FINEOS Corporation Holdings plc (ASX: FCL) have soared almost 90% higher so far this year. Despite the market challenges posed by the COVID-19 pandemic, FINEOS has managed to achieve a number of impressive milestones in 2020, including signing the largest insurance company in the United States and recently acquiring software company Limelight Health, Inc.

FINEOS develops a suite of software for the life, accident and health insurance industries. Its AdminSuite platform is a centralised system that supports billing, claims and payments. Its customer-centric software automates and streamlines processes for insurance providers and can replace legacy insurance administration platforms.

In its FY20 results, Dublin-based FINEOS beat its own revenue targets, reporting growth in revenues of close to 40% year on year. Of the 87.8 million euros in total revenues in FY20, 27 million euros came from recurring subscriptions, while 58.3 million euros was services revenue from new clients and accelerated implementation and upgrades for existing clients. And despite the ongoing disruptions from COVID-19, the company is still optimistic for FY21, forecasting top line revenue growth of 20%, underpinned by 30% growth in subscription revenues.

The Limelight acquisition could help to rapidly accelerate the company's growth forecasts. Silicon Valley-based Limelight Health is a leading provider of software for the United States insurance industry. The acquisition helps boost FINEOS' presence in the US market, and it means that FINEOS can now leverage Limelight's experienced US-based sales and marketing team to increase market penetration and brand recognition.

This also comes on the heels of FINEOS' February announcement that it had signed the Prudential Insurance Company of America, the largest insurance company in the US. FINEOS is clearly sending the signal to the market that it views a US expansion as a key priority over the next 12 months.

Should you invest?

Along with other up-and-coming tech companies like Nitro Software Ltd (ASX: NTO), Bigtincan Holdings Ltd (ASX: BTH) and Megaport Ltd (ASX: MP1), I believe FINEOS Corporation is cementing itself as part of a new generation of young companies that could become the next WAAAX shares. Despite the upheaval caused by the pandemic, these junior companies have all found ways to thrive.

With a market capitalisation of a little over $1.5 billion, FINEOS has grown into a solid mid-cap stock. It is generating consistent subscription revenues and has a portfolio of top tier insurance companies as clients. It is taking on additional risk through a US expansion, however this is already showing results through key client wins. Plus, it has shown an appetite for strategic acquisitions that could complement its business model.

Despite challenging market conditions, I believe this company has laid a solid foundation for future growth. The FINEOS share price will be an exciting one to watch over the next 12 months.

Rhys Brock owns shares of FINEOS Holdings plc, BIGTINCAN FPO, MEGAPORT FPO, and Nitro Software Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends BIGTINCAN FPO and MEGAPORT FPO. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends FINEOS Holdings plc. The Motley Fool Australia has recommended BIGTINCAN FPO, FINEOS Holdings plc, MEGAPORT FPO, and Nitro Software Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »